Oral administration of pyrophosphate inhibits connective tissue calcification
2017 · EMBO Molecular Medicine · 119 citations
https://doi.org/10.15252/emmm.201707532
E
Emmanuel Letavernier
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
291
Papers
5.6K
Citations
45
h-index
123
i10-index
Emmanuel Letavernier is an academic researcher from Inserm. The author has contributed to research in topics: Kidney Stones and Urolithiasis Treatments & Parathyroid Disorders and Treatments & Pediatric Urology and Nephrology Studies. The author has an h-index of 45, co-authored 248 publications.
ORCID: 0000-0002-6053-8975Papers by this author
worksABCC6 Deficiency Promotes Development of Randall Plaque
2018 · Journal of the American Society of Nephrology · 62 citations
https://doi.org/10.1681/asn.2017101148
Vitamin D and Calcium Supplementation Accelerates Randall's Plaque Formation in a Murine Model
2019 · American Journal Of Pathology · 44 citations
https://doi.org/10.1016/j.ajpath.2019.07.013
Pseudoxanthoma Elasticum, Kidney Stones and Pyrophosphate: From a Rare Disease to Urolithiasis and Vascular Calcifications
2019 · International Journal of Molecular Sciences · 31 citations
https://doi.org/10.3390/ijms20246353
Calpastatin prevents Angiotensin II–mediated podocyte injury through maintenance of autophagy
2021 · Kidney International · 29 citations
https://doi.org/10.1016/j.kint.2021.02.024
Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension
2016 · American Journal of Respiratory Cell and Molecular Biology · 23 citations
https://doi.org/10.1165/rcmb.2015-0257oc
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat